{
    "organizations": [],
    "uuid": "4f6da2cd4e15d6cb7252c1e072069ce6b611cca2",
    "author": "",
    "url": "https://www.reuters.com/article/brief-clovis-oncology-says-sec-issued-we/brief-clovis-oncology-says-sec-issued-wells-notices-to-co-certain-of-its-officers-idUSFWN1RN0MZ",
    "ord_in_thread": 0,
    "title": "BRIEF-Clovis Oncology Says SEC Issued 'Wells Notices' To Co & Certain Of Its Officers",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 10, 2018 / 1:37 PM / in 5 minutes BRIEF-Clovis Oncology Says SEC Issued 'Wells Notices' To Co & Certain Of Its Officers Reuters Staff 1 Min Read \nApril 10 (Reuters) - Clovis Oncology Inc: \n* CLOVIS ONCOLOGY SAYS ON APRIL 9 SEC ISSUED ‘WELLS NOTICES’ TO CO & CERTAIN OF ITS CURRENT AND FORMER OFFICERS - SEC FILING \n* SEC’S ‘WELLS NOTICES’ ALLEGES VIOLATIONS OF SOME PROVISIONS OF SECURITIES ACT OF 1933 AND SECURITIES EXCHANGE ACT OF 1934 \n* ALLEGED VIOLATIONS RELATE TO CO'S REGULATORY UPDATE IN NOV 2015 THAT FDA REQUESTED MORE CLINICAL DATA ON EFFICACY, SAFETY OF ROCILETINIB Source text: ( bit.ly/2IDAEmj ) Further company coverage:",
    "published": "2018-04-10T16:35:00.000+03:00",
    "crawled": "2018-04-10T16:47:46.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "minute",
        "oncology",
        "say",
        "sec",
        "issued",
        "notice",
        "co",
        "certain",
        "officer",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "clovis",
        "oncology",
        "inc",
        "clovis",
        "oncology",
        "say",
        "april",
        "sec",
        "issued",
        "well",
        "notice",
        "co",
        "certain",
        "current",
        "former",
        "officer",
        "sec",
        "filing",
        "sec",
        "well",
        "notice",
        "alleges",
        "violation",
        "provision",
        "security",
        "act",
        "security",
        "exchange",
        "act",
        "alleged",
        "violation",
        "relate",
        "co",
        "regulatory",
        "update",
        "nov",
        "fda",
        "requested",
        "clinical",
        "data",
        "efficacy",
        "safety",
        "rociletinib",
        "source",
        "text",
        "company",
        "coverage"
    ]
}